FDA Advisers Call for Cardiovascular-Safety Assessment of New Di...

Courtesy MedPage Today Infectious Disease  Thu, 07/03/2008 - 11:37

ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers.

Sponsors

 

Related items

JCI online early table of contents: Sept. 5, 2008
(Journal of Clinical Investigation) This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be...

Rhode Island Hospital study finds link between obesity, type 2...
(Lifespan) New research from Rhode Island Hospital found that obesity and Type 2 Diabetes Mellitus can contribute to mild neurodegeneration with...

Are diabetes and obesity linked to periodontitis?
(University of Illinois at Chicago) The University of Illinois at Chicago has received a two-year federal grant to continue a study on how...

Class of diabetes drugs carries significant cardiovascular risks
(Wake Forest University Baptist Medical Center) A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an...

Diabetes Drug Byetta: 6 Deaths Reported
Six patients taking the type 2 diabetes drug Byetta (exenatide) are now reported to have died after developing pancreatitis.


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com